Biolayer Interferometry-based FcγRIIa binding assay for a therapeutic antibody with strong effector function.
Sign Up to like & getrecommendations! Published in 2020 at "Analytical biochemistry"
DOI: 10.1016/j.ab.2020.113842
Abstract: FcγRIIa receptor binding is part of the mechanism of action for many therapeutic antibodies. AlphaScreen® technology and Biolayer Interferometry (BLI) are often used to assess protein-protein interactions. Recently we demonstrated that the presence of aggregates… read more here.
Keywords: based riia; riia; binding assay; biolayer interferometry ... See more keywords